- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07071324
CF Wellness Program for Fatigue and Sleep in Cystic Fibrosis - ORBIT Phase 2 Study
Cystic fibrosis (CF) patients often struggle with debilitating fatigue and poor sleep quality, even with modern highly effective modulator therapies (HEMT). This important clinical trial evaluates a novel CF Wellness Program (CFWP) combining cognitive behavioral therapy (CBT) and physical activity coaching to address these overlooked symptoms.
The study builds on concerning findings that 43% of CF adults experience elevated fatigue and 63% report poor sleep quality despite HEMT treatment. These symptoms significantly impact quality of life and disease outcomes. The CFWP offers a structured 8-session virtual program covering:
- Fatigue management strategies
- Sleep improvement techniques
- Personalized physical activity planning
- Emotional wellbeing support
- Stress reduction methods
As a randomized controlled trial, the study will compare 80 participants receiving either the CFWP intervention or usual care. Researchers will track session attendance, collect fitness tracker data, and measure changes in fatigue (using FACIT-F scale), sleep quality (PSQI and ISI), and activity levels.
For CF patients and caregivers, this research addresses critical gaps in holistic care. While HEMT drugs target lung function, many patients continue experiencing "invisible symptoms" like exhaustion and insomnia that dramatically affect daily life. The virtual delivery format makes the program potentially accessible to patients across different locations.
This pilot study represents an important step toward comprehensive CF care. Positive results could establish CBT and activity coaching as standard adjunct therapies. The research team includes leading CF specialists from Johns Hopkins University, National Jewish Health, and Boston Children's Hospital, with funding from the Cystic Fibrosis Foundation.
Future implications may extend beyond CF, as the intervention model could potentially benefit other chronic illnesses where fatigue and sleep disturbances significantly impact quality of life. The study's focus on measurable outcomes and practical delivery methods increases the likelihood that successful results could be quickly implemented in clinical practice.
Upcoming Clinical Trials
-
NCT07664137Not yet recruiting
-
NCT07664176Not yet recruitingMedulloblastoma Recurrent | Ependymoma Recurrent | Brain Tumor Recurrent | High Grade Gliomas | Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS | Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma
-
NCT07664202RecruitingClavicle Fracture
-
NCT07664228RecruitingIgA Vasculitis | Gastrointestinal Involvement
-
NCT07664241Not yet recruitingMalignant Head and Neck Neoplasm
-
NCT07664280RecruitingSkin Aging | Wrinkles | Facial Aging
-
NCT07664332Not yet recruiting
-
NCT07664345Not yet recruitingOxidative Stress | Exercise Recovery | Exercise-induced Muscle Damage | Sports Performance | Aerobic Capacity
-
NCT07664358Not yet recruitingTBI (Traumatic Brain Injury) | ARDS | Fibrinogen Albumin Ratio
-
NCT07664384Not yet recruitingRetrograde Intrarenal Surgery
-
NCT07664397Not yet recruitingBladder Cancer | Advanced Solid Tumor | Nerve Sheath Neoplasms | Solid Tumor Cancer | Solid Tumor, Adult | Solid Carcinoma | Bladder Neoplasm | Solid Tumor Malignancies | Nerve Sheath Tumors | Nerve Sheath Tumor